A new series of 4-methyl-7-methoxycoumarin derivati ves linked triazoles and oxadiazole were prepared s tarting from 2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy) acetoh ydrazide, compound 4 . The purity of all new compounds was checked by TLC and elucidation of their structures was confirmed by IR , 1 H and 13 C NMR along with High Resolution Mass Spectrometry ( HRMS ). All the target compounds were evaluated for their possible anti- inflammatory activities. The result showed that mos t of the tested compounds exhibited significant ant i-inflammatory activity in comparison to indomethacin as a referen ce drug. The compound 8l was the most active one. Compounds 6a , 8g , 8i , 8k and 8l were tested for their analgesic effects in compari son to indomethacin as a reference drug. Compounds 6a and 8i showed activity comparable to the reference drug. Compounds 6a , 8d and 8l were examined for their effect on gastric mucosa and showed no ga stric ulcerogenic effect at dose 60 mg/Kg. Moreover , LD 50 of compounds 6a and 8l were determined; they exhibited no-toxic effect up to 240 and 300 mg/kg (i.p.) respectively. Finally, compounds 7 and 8a-8j were evaluated for their possible antimicrobial ac tivity. Most of the tested compounds showed moderate to good antimicrobial act ivity against most of the strains used in compariso n with ciprofloxacin and fluconazole as reference drugs.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report